Sign In

Antoine Barouky

Global Biotechnology Executive - Board Member

Professional Background

Antoine Barouky is a seasoned professional with over 25 years of diverse experience in the pharmaceutical and healthcare industries, showcasing an impressive ability to navigate the complex landscape of global product positioning and business development. His career is marked by a commitment to excellence and a proven track record of driving growth and transformation in various high-stakes environments. Antoine's expertise spans across more than 50 markets including Europe, the United States, the Middle East, Canada, Asia, and Latin America.

One of Antoine's most notable achievements includes a remarkable 12-year tenure at one of the leading pharmaceutical companies, during which he played a pivotal role in transforming the business from €40 million to an astounding €235 million in sales. This extraordinary growth largely stemmed from his strategic initiatives in launching new products across all EU countries. Additionally, he successfully opened new subsidiaries in the US and a range of out-licensing deals across Canada, Japan, and EMEA, further enhancing the global footprint of the company. His leadership was instrumental during the change of control following an acquisition by private equity, which paved the way for two successful mergers and acquisitions in the United States.

Antoine has also demonstrated his knack for turnaround strategies, particularly in the area of rare diseases. At Shire France, he skillfully orchestrated a turnaround of the rare diseases business unit, which has had significant implications for patients dealing with disorders such as Fabry disease, Gaucher disease, MPS/Hunter syndrome, and HAE (Hereditary Angioedema). His strategic focus and operational excellence in launching and managing hospital and retail products for rare and critical care diseases have made him a sought-after leader in the industry.

Education and Achievements

Antoine Barouky's educational background lays a strong foundation for his impressive career in the life sciences sector. He studied Finance at the prestigious HEC Paris, where he developed a deep understanding of financial markets and economic principles that are essential in today’s competitive business environment. To further enhance his leadership capabilities, he completed a Management Acceleration Programme at INSEAD, one of the world’s leading business schools known for its rigorous approach to leadership education.

Additionally, Antoine pursued studies in Engineering with a specialization in Biochemistry and Biotechnology at INSA Lyon. This technical background not only complements his business acumen but also equips him with the scientific knowledge essential for making informed decisions in the pharmaceutical industry. His multidisciplinary education underpins his ability to translate complex scientific principles into effective business strategies.

Achievements

Throughout his illustrious career, Antoine has held several prominent positions that reflect his expertise and leadership. Currently, he serves as the Vice President General Manager & International Business Development at Alnylam Pharmaceuticals, where he continues to leverage his extensive experience to drive commercial success. Previously, he was a Member of the Board of Directors at ILTOO PHARMA, demonstrating his leadership and governance skills within the pharmaceutical industry.

Before his tenure at Alnylam, he served as Vice President and General Manager at remarkable organizations such as Cubist Pharmaceuticals, where he managed operations in France and the Benelux region. His strategic vision as Senior Vice President, Business and Corporate Development at Stallergenes further exemplifies his broad scope of influence in the field, overseeing global marketing, medical affairs, and business planning initiatives.

Antoine has significantly contributed to the success of each organization he has been a part of, navigating the challenges of various market conditions while driving product launches, establishing market access strategies, and enhancing operational efficiency.

His career highlights the successful management of rare diseases, where his focused initiatives and innovative approaches have had lasting impacts on patient care. Today, Antoine Barouky is recognized as an industry expert and a strategic leader, paving the way for future innovations in the pharmaceutical landscape.

Related Questions

How did Antoine Barouky navigate the complexities of launching products in over 50 global markets?
What innovative strategies did Antoine Barouky implement to achieve a sales increase from €40 million to €235 million?
In what ways has Antoine Barouky contributed to the advancement of rare disease treatments during his career?
How has Antoine Barouky's educational background in finance and biochemistry influenced his approach to product development and business management?
What challenges did Antoine Barouky face during the M&A processes he led, and how did he overcome them?
Antoine Barouky
Add to my network

Location

Greater Paris Metropolitan Region